Compare BHST & MLCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | BHST | MLCI |
|---|---|---|
| Founded | 2007 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Investment Managers |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.3M | 33.7M |
| IPO Year | 2017 | 2026 |
| Metric | BHST | MLCI |
|---|---|---|
| Price | $1.89 | $3.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 43.7K | 25.5K |
| Earning Date | 05-15-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 2.63% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $53,566,000.00 |
| Revenue This Year | $146.27 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.58 |
| 52 Week Low | $1.80 | $2.56 |
| 52 Week High | $12.80 | $8.68 |
| Indicator | BHST | MLCI |
|---|---|---|
| Relative Strength Index (RSI) | 35.52 | 48.82 |
| Support Level | $1.82 | $2.65 |
| Resistance Level | $2.99 | $3.54 |
| Average True Range (ATR) | 0.10 | 0.17 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 12.16 | 41.16 |
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.
Mount Logan Capital Inc operates as emerging asset management and investment firm focused on investing in public and private debt securities in the North American market. The company's reporting segments include asset management and insurance. The company through its subsidiaries, earns management and incentive fees and servicing fees for providing investment management, monitoring and other services to investment vehicles and advisers. The Asset Management segment comprises all fee generating activities. The Insurance Solutions segment, which derives maximum revenue, consists of two product lines within the insurance business, LTC and MYGA.